NO970127L - Topiske sammensetninger for behandling av hudsykdom - Google Patents
Topiske sammensetninger for behandling av hudsykdomInfo
- Publication number
- NO970127L NO970127L NO970127A NO970127A NO970127L NO 970127 L NO970127 L NO 970127L NO 970127 A NO970127 A NO 970127A NO 970127 A NO970127 A NO 970127A NO 970127 L NO970127 L NO 970127L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- hydrogen
- lower alkyl
- independently
- treatment
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000017520 skin disease Diseases 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- -1 amino, hydroxy Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Sammensetning egnet for topisk administrering for behandling av en hyperproiifcrativ hudsykdom som er en gel omfattende (A) en forbindelse med formelen Ar, A,-N Aj-N Ar, O // N-R a) hvor Al og A2 hver er uavhengig av hverandre hydrogen, lavere alkyl, lavere alkenyl, lavere alk7nyl, aryl, acyl, lavere alkylsulfonyl eller arylsulfonyl; eller hvor A\ og A2 sammen danner usubstituert eller lavere alkyl- eller hydroksy-substituert lavere alkylen; At] og Ar2 er hver uavhengig av hverandre aryl, heteroaryl eller usubstituert eller substituert cyklDalk7l; gruppen -C(=X)- er -C(=0)-, -C(=S)-, -CH2- eller - C(=CRi R2)- hvor Rj og R2 er hver, uavhengig av hverandre, hydrogen eller lavere alkyl; og R er hydrogen, lavere alkyl, aryl-lavere alkyl, aryl, amino, hydroksy eller lavere alkoksy; forutsatt at R er forskjellig fra fenyl når A] og A2 er hydrogen. Ar] og Ar2 er fenyl og gmppen -C(=X)- er -C(=G)-; eller et farmasoyiisk akseptabelt salt derav når en saltdannende gruppe er tilstede; (B) enCi-C4 alkylmonoeter av dietylenglykol, (C) et geldarmende middel, og (D) et opnlosningsm.iddel som er blandbart med (B).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600545.9A GB9600545D0 (en) | 1996-01-11 | 1996-01-11 | Compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO970127D0 NO970127D0 (no) | 1997-01-10 |
| NO970127L true NO970127L (no) | 1997-07-14 |
Family
ID=10786892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970127A NO970127L (no) | 1996-01-11 | 1997-01-10 | Topiske sammensetninger for behandling av hudsykdom |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0783887A3 (no) |
| JP (1) | JPH09194371A (no) |
| KR (1) | KR970058711A (no) |
| AU (1) | AU1002697A (no) |
| CA (1) | CA2194730A1 (no) |
| GB (1) | GB9600545D0 (no) |
| HU (1) | HUP9700079A2 (no) |
| IL (1) | IL119990A0 (no) |
| MX (1) | MX9700324A (no) |
| NO (1) | NO970127L (no) |
| ZA (1) | ZA97253B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9173835B2 (en) * | 2005-05-10 | 2015-11-03 | Dermipsor Ltd. | Compositions and methods for treating hyperproliferative epidermal diseases |
| WO2018118874A1 (en) * | 2016-12-19 | 2018-06-28 | Chromaderm, Inc. | Methods of treating hyperpigmentation disorders |
| WO2023225373A1 (en) | 2022-05-20 | 2023-11-23 | Dermbiont, Inc. | Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU653024B2 (en) | 1991-05-30 | 1994-09-15 | Novartis Ag | Substituted diaminophthalimides and analogues |
| WO1994007895A1 (en) * | 1992-09-25 | 1994-04-14 | Schering Corporation | Diindolo compounds and pharmaceutical compositions containing them |
| AU686691B2 (en) * | 1994-01-12 | 1998-02-12 | F. Hoffmann-La Roche Ag | Novel azepanes and homologs thereof |
-
1996
- 1996-01-11 GB GBGB9600545.9A patent/GB9600545D0/en active Pending
- 1996-12-23 EP EP96309403A patent/EP0783887A3/en not_active Withdrawn
-
1997
- 1997-01-03 AU AU10026/97A patent/AU1002697A/en not_active Abandoned
- 1997-01-09 CA CA002194730A patent/CA2194730A1/en not_active Abandoned
- 1997-01-10 IL IL11999097A patent/IL119990A0/xx unknown
- 1997-01-10 HU HU9700079A patent/HUP9700079A2/hu unknown
- 1997-01-10 MX MX9700324A patent/MX9700324A/es unknown
- 1997-01-10 KR KR1019970000448A patent/KR970058711A/ko not_active Withdrawn
- 1997-01-10 JP JP9002503A patent/JPH09194371A/ja active Pending
- 1997-01-10 NO NO970127A patent/NO970127L/no unknown
- 1997-01-13 ZA ZA97253A patent/ZA97253B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9700079A2 (hu) | 1998-05-28 |
| KR970058711A (ko) | 1997-08-12 |
| NO970127D0 (no) | 1997-01-10 |
| AU1002697A (en) | 1997-07-17 |
| EP0783887A2 (en) | 1997-07-16 |
| MX9700324A (es) | 1998-04-30 |
| GB9600545D0 (en) | 1996-03-13 |
| ZA97253B (en) | 1997-07-13 |
| JPH09194371A (ja) | 1997-07-29 |
| IL119990A0 (en) | 1997-04-15 |
| HU9700079D0 (en) | 1997-02-28 |
| CA2194730A1 (en) | 1997-07-12 |
| EP0783887A3 (en) | 1999-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2225404C2 (ru) | ПРОИЗВОДНЫЕ ПИПЕРАЗИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ФАКТОРА Хa | |
| EA200100766A1 (ru) | Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов | |
| EP1362846A4 (en) | AMINOETHANOL DERIVATIVES | |
| DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
| AR020032A1 (es) | Derivados de 1,3 -metil eritromicina. | |
| BR9914221B1 (pt) | Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos | |
| BRPI0413232B8 (pt) | composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto | |
| FI921030A0 (fi) | Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| TR199901578T2 (xx) | Klaritromisin form 0 kristali | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| KR970704677A (ko) | 의약으로서의 벤조일구아니딘 유도체(Benzovlguanidine Derivatives as Medicaments) | |
| TR200103349T2 (tr) | Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri. | |
| TR200101868T2 (tr) | Sülfonamit hidroksamatlar. | |
| CA2334863A1 (en) | Antithrombotic compounds | |
| UA50711C2 (uk) | Антрациклінові похідні, їх застосування при лікуванні амілоїдозу та фармацевтична композиція | |
| AR004777A1 (es) | Uso de derivados de 2-tioxo-imidazolidin-4-ona para la preparacion de medicamentos y medicamentos que los contiene. | |
| EA199801028A1 (ru) | Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний | |
| HUP9904210A2 (hu) | Kamptotecin-analógok, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| NO970127L (no) | Topiske sammensetninger for behandling av hudsykdom | |
| KR970074773A (ko) | 신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2, 4-피리미딘디온 유도체 및 그의 제조 방법 | |
| AR034692A1 (es) | Inhibidores de la integrina alfavbeta3, un procedimiento para su preparacion, los medicamentos a base de estos compuestos, las composiciones farmaceuticas que los contienen y el uso de los mismos para preparar un medicamento destinado a combatir enfermedades que se basan en la expresion y funcion pa | |
| AR020030A1 (es) | FORMAS CRISTALINAS DE UN ANTIBIoTICO MACRoLIDO; COMPOSICION FARMACÉUTICA Y PROCEDIMIENTO PARA SU PREPARACION. | |
| MX9405111A (es) | Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina). | |
| HUP0105111A1 (hu) | 2,5-Helyettesített benzolszulfonilkarbamid- és tiokarbamidszármazékok, eljárás előállításukra, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| SE8007025L (sv) | Derivat av 1,2,4-oxadiazolin-5-on, sett for deras framstellning och farmaceutiska beredningar innehallande dem |